1. Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation. Chyla BJ, Moreno-Miralles I, Steapleton MA, Thompson MA, Bhaskara S, Engel M, Hiebert SW (2008) Mol Cell Biol 28(20): 6234-47
    › Primary publication · 18710942 (PubMed) · PMC2577421 (PubMed Central)
  2. Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Bhaskara S, Chyla BJ, Amann JM, Knutson SK, Cortez D, Sun ZW, Hiebert SW (2008) Mol Cell 30(1): 61-72
    › Primary publication · 18406327 (PubMed) · PMC2373760 (PubMed Central)
  3. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW (2002) Nat Med 8(7): 743-50
    › Primary publication · 12091906 (PubMed)
  4. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins. Barseguian K, Lutterbach B, Hiebert SW, Nickerson J, Lian JB, Stein JL, van Wijnen AJ, Stein GS (2002) Proc Natl Acad Sci U S A 99(24): 15434-9
    › Primary publication · 12427969 (PubMed) · PMC137734 (PubMed Central)
  5. Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype. King D, Yang G, Thompson MA, Hiebert SW (2002) Oncogene 21(32): 4978-82
    › Primary publication · 12118376 (PubMed)
  6. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. de Guzman CG, Warren AJ, Zhang Z, Gartland L, Erickson P, Drabkin H, Hiebert SW, Klug CA (2002) Mol Cell Biol 22(15): 5506-17
    › Primary publication · 12101243 (PubMed) · PMC133929 (PubMed Central)
  7. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Wang L, Hiebert SW (2001) Oncogene 20(28): 3716-25
    › Primary publication · 11439334 (PubMed)
  8. Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins. Hiebert SW, Lutterbach B, Amann J (2001) Curr Opin Hematol 8(4): 197-200
    › Primary publication · 11561155 (PubMed)
  9. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, Downing JR, Meyers S, Hiebert SW (2001) Mol Cell Biol 21(19): 6470-83
    › Primary publication · 11533236 (PubMed) · PMC99794 (PubMed Central)
  10. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW (2001) Oncogene 20(8): 910-20
    › Primary publication · 11314026 (PubMed)